NILSA MARTINEZ: Open Payments
NPI 1215929187 · HILTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 62 payments from 18 companies in 2025. Trend: 2023 $170 · 2024 $822 · 2025 $1,141
Food & beverage: $1,141
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $374 |
| Novo Nordisk Inc | 12 | $217 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| PFIZER INC. | 5 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Exact Sciences Corporation | 2 | $46 |
| Lilly USA, LLC | 2 | $34 |
| SANOFI PASTEUR INC. | 1 | $29 |
| Verona Pharma, Inc. | 1 | $27 |
| ALK-Abello, Inc | 1 | $26 |
Products named: VRAYLAR, UBRELVY, Ozempic, QULIPTA, NURTEC ODT, Wegovy, CAPLYTA, FARXIGA.
Industry payments across NY — which companies pay providers there.
